// App-Quantinova.ai

1545 : Long-Term Use of Low-Molecular-Weight Heparin (LMWH) for Cancer-Associated Venous Thromboembolism (VTE): Adherence to Recommendations in Clinical Practice Based on Tropique, a Prospective Non-Interventional Observational Study

Researchers

Presenter

  • Dominique Farge

Principal Investigators

  • Norbert Claude Gorin

  • Philippe Debourdeau

  • Anne Lamblin

  • Francis Cajfinger

Medical Centers

  • Institut Sainte Catherine, Avignon, France

  • department of Hematology and Cell therapy, Hospital Saint-Antoine, Paris University UPMC, INSERM U938, Paris, France

  • Gruope Hospitalier Pitie-Salpetriere, Paris, France

  • Hospital Saint Antoine, Paris, France

  • Leo-Pharma, Voisins le Bretonneux, France

  • EBMT Acute Leukemia Working Party and Registry, Department of hematology and cell therapy, Hospital Saint-Antoine, Paris University, Paris, France

Locations

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Venous thrombosis

  • Renal insufficiency

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • Heparin

Outcome

  • N/A

Study Design

  • observational

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved